|
|
||||||||
2-Adrenergic
receptor-selective agonist clenbuterol prevents Fas-induced liver
apoptosis and death in mice
1 Institut National de la Santé et de la Recherche Médicale (INSERM) U380, 2 INSERM U445, and 3 INSERM U363, Institut Cochin de Génétique Moléculaire, Université René Descartes, 75014 Paris, France
Stimulation of the
cAMP-signaling pathway modulates apoptosis in several cell types and
inhibits Jo2-mediated apoptosis in cultured rat hepatocytes. No
information is yet available as to whether the hepatic
2-adrenergic receptor (AR)
expression level, including
2-AR-dependent adenylyl cyclase
activation, modulates hepatocyte sensitivity to apoptosis in vivo or
whether this sensitivity can be modified by
2-AR ligands. We have examined
this using C57BL/6 mice, in which hepatic
2-AR densities are low, and
transgenic F28 mice, which overexpress
2-ARs and have elevated basal
liver adenylyl cyclase activity. The F28 mice were resistant to
Jo2-induced liver apoptosis and death. The
-AR antagonist
propranolol sensitized the F28 livers to Jo2. In normal mice
clenbuterol, a
2-AR-specific agonist, considerably reduced Jo2-induced liver apoptosis and death;
salbutamol, another
2-AR-selective agonist, also
reduced Jo2-induced apoptosis and retarded death but with less efficacy than clenbuterol; and propranolol blocked the protective effect of
clenbuterol. This indicates that the expression level of functional
2-ARs modulates Fas-regulated
liver apoptosis and that this apoptosis can be inhibited in vivo by
giving
2-AR agonists. This may
well form the basis for a new therapeutic approach to diseases
involving abnormal apoptosis.
-adrenoceptor antagonist; C57BL/6 mouse; transgenic F28 mouse; anti-Fas monoclonal antibody
This article has been cited by other articles:
![]() |
A. Gates, S. Hohenester, M. S. Anwer, and C. R. L. Webster cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 {beta}/{alpha} in rat hepatocytes Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G764 - G774. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Erraji-Benchekroun, D. Couton, C. Postic, I. Borde, J. Gaston, J.-G. Guillet, and C. Andre Overexpression of {beta}2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E715 - E722. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. L. Webster, P. Usechak, and M. S. Anwer cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G727 - G738. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Communal, W. S. Colucci, and K. Singh p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against beta -Adrenergic Receptor-stimulated Apoptosis. EVIDENCE FOR Gi-DEPENDENT ACTIVATION J. Biol. Chem., June 16, 2000; 275(25): 19395 - 19400. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |